These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 21565826)
1. MLH1-93G > A is a risk factor for MSI colorectal cancer. Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826 [TBL] [Abstract][Full Text] [Related]
2. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836 [TBL] [Abstract][Full Text] [Related]
3. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers. Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847 [TBL] [Abstract][Full Text] [Related]
4. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer. Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285 [TBL] [Abstract][Full Text] [Related]
5. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer. Martínez-Urueña N; Macías L; Pérez-Cabornero L; Infante M; Lastra E; Cruz JJ; Miner C; González R; Durán M Colorectal Dis; 2013 Mar; 15(3):e118-23. PubMed ID: 23374646 [TBL] [Abstract][Full Text] [Related]
6. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer. Mrkonjic M; Roslin NM; Greenwood CM; Raptis S; Pollett A; Laird PW; Pethe VV; Chiang T; Daftary D; Dicks E; Thibodeau SN; Gallinger S; Parfrey PS; Younghusband HB; Potter JD; Hudson TJ; McLaughlin JR; Green RC; Zanke BW; Newcomb PA; Paterson AD; Bapat B PLoS One; 2010 Oct; 5(10):e13314. PubMed ID: 20967208 [TBL] [Abstract][Full Text] [Related]
7. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer. Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R J BUON; 2011; 16(2):265-73. PubMed ID: 21766496 [TBL] [Abstract][Full Text] [Related]
9. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Lawes DA; Pearson T; Sengupta S; Boulos PB Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253 [TBL] [Abstract][Full Text] [Related]
10. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982 [TBL] [Abstract][Full Text] [Related]
11. MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Allan JM; Shorto J; Adlard J; Bury J; Coggins R; George R; Katory M; Quirke P; Richman S; Scott D; Scott K; Seymour M; Travis LB; Worrillow LJ; Bishop DT; Cox A; ; Int J Cancer; 2008 Nov; 123(10):2456-9. PubMed ID: 18712731 [TBL] [Abstract][Full Text] [Related]
12. The dynamic DNA methylation landscape of the Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327 [TBL] [Abstract][Full Text] [Related]
13. Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity. Perera S; Mrkonjic M; Rawson JB; Bapat B Oncol Rep; 2011 Mar; 25(3):809-15. PubMed ID: 21206982 [TBL] [Abstract][Full Text] [Related]
14. Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry. Levine AJ; Win AK; Buchanan DD; Jenkins MA; Baron JA; Young JP; Long TI; Weisenberger DJ; Laird PW; McCall RL; Duggan DJ; Haile RW Cancer Prev Res (Phila); 2012 Feb; 5(2):328-35. PubMed ID: 22144422 [TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Poynter JN; Siegmund KD; Weisenberger DJ; Long TI; Thibodeau SN; Lindor N; Young J; Jenkins MA; Hopper JL; Baron JA; Buchanan D; Casey G; Levine AJ; Le Marchand L; Gallinger S; Bapat B; Potter JD; Newcomb PA; Haile RW; Laird PW; Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3208-15. PubMed ID: 18990764 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients. Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381 [TBL] [Abstract][Full Text] [Related]
17. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability. Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058 [TBL] [Abstract][Full Text] [Related]
19. Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. Hubner RA; Houlston RS J Natl Cancer Inst; 2007 Oct; 99(19):1490; author reply 1490-1. PubMed ID: 17895478 [No Abstract] [Full Text] [Related]
20. Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis. Chen H; Shen Z; Hu Y; Xiao Q; Bei D; Shen X; Ding K J Cancer Res Clin Oncol; 2015 Dec; 141(12):2147-58. PubMed ID: 25986311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]